Atlas Trials

National Cancer Centre, Singapore

115 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch National Cancer Centre, Singapore

RecordFirmDate
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP) (NCT07521670)National Cancer Centre, Singapore2026-11-01
Effectiveness and Implementation of 'Supportive and Palliative Care Review Kit in Locations Everywhere' (NCT07745816)National Cancer Centre, Singapore2026-08-01
Restoring Bile Acid Homeostasis Via Lifestyle Adjustments to Prevent the Development of Liver Cancer (NCT07111130)National Cancer Centre, Singapore2026-07-01
Electroacupuncture for Cognitive Toxicity in Cancer Survivors: Assessing Implementation, Cost, and Effectiveness for Integration (NCT07583979)National Cancer Centre, Singapore2026-07-01
Sensory Enrichment Using Aromatherapy for Neurobehavioral and Psychological Symptoms in Early Dementia (NCT07234357)National Cancer Centre, Singapore2026-06-09
Histotripsy for Ablation of Liver Tumours in Asia (NCT07428356)National Cancer Centre, Singapore2025-11-07
Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore (NCT07116161)National Cancer Centre, Singapore2025-07-14
Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal (NCT06977360)National Cancer Centre, Singapore2025-05-23
Intramuscular ACM-CpG Monotherapy in Patients With Advanced/Metastatic Solid Tumors With Prior Response to Immunotherapy Alone or in Combination With Chemotherapy (NCT06587295)National Cancer Centre, Singapore2025-01-15
Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. (NCT06766058)National Cancer Centre, Singapore2024-10-22
Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE) (NCT06956248)National Cancer Centre, Singapore2024-09-12
Timely Interventions to Enable and Reach Patients With Heart Failure, and Their Caregivers With Palliative Care (NCT06244953)National Cancer Centre, Singapore2024-08-14
Tislelizumab and Metronomic Capecitabine as Maintenance in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma (NCT06093061)National Cancer Centre, Singapore2024-07-03
Pembrolizumab and Olaparib Treatment for Relapsed or Refractory Peripheral T-Cell Lymphoma (NCT06160843)National Cancer Centre, Singapore2024-07-01
A Pan-Asian Clinical Database of EGFR Exon 20 Insertion Mutated NSCLC (NCT06418412)National Cancer Centre, Singapore2024-03-15
Metronomic Capecitabine, Oxaliplatin and UGT1A1 Genotype-directed Irinotecan in Metastatic Pancreatic Cancer Patients (NCT05929885)National Cancer Centre, Singapore2023-08-30
A Phase 2 Study of Osimertinib and S-1 in Treatment Resistant EGFR Mutant NSCLC (NCT05773092)National Cancer Centre, Singapore2023-08-01
Breast Cancer Exercise Intervention Study (NCT05957068)National Cancer Centre, Singapore2023-07-01
Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in (NCT05198479)National Cancer Centre, Singapore2023-05-05
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma (NCT05516628)National Cancer Centre, Singapore2023-02-28
Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers (NCT06194084)National Cancer Centre, Singapore2023-02-01
tReatment Individualisation By EBV stratificatiON in Nasopharyngeal Carcinoma: an Umbrella Platform Study (RIBBON-Umbrella) (NCT05517135)National Cancer Centre, Singapore2022-11-17
SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE) (NCT05724264)National Cancer Centre, Singapore2022-07-21
ENABLE (Educate, Nurture, Advise, Before Life Ends) Intervention for Heart Failure (HF) Patients and Their Caregivers in Singapore (NCT05211882)National Cancer Centre, Singapore2022-02-14
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers (NCT05581979)National Cancer Centre, Singapore2022-01-26
Increasing Uptake of Cascade Testing in Families With Familial Cancer Syndromes: A Randomized Controlled Trial of a Registry-aided Model. (NCT07626814)National Cancer Centre, Singapore2021-12-10
Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma (NCT05148572)National Cancer Centre, Singapore2021-11-10
Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers (NCT04946968)National Cancer Centre, Singapore2021-08-24
PIPAC for Peritoneal Metastases (NCT04956068)National Cancer Centre, Singapore2021-05-20
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE) (NCT04965259)National Cancer Centre, Singapore2021-04-15
Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC (NCT04912765)National Cancer Centre, Singapore2021-04-15
Impact of a Breast cAncer Survivorship Interprofessional Community Care Model (NCT04660188)National Cancer Centre, Singapore2021-03-01
Novel Palliative Care Model for Advanced Cancer Patients: A Randomized Controlled Trial Study (NCT04242251)National Cancer Centre, Singapore2021-02-08
Telegenetics or In-Person Genetic Counselling (NCT04738708)National Cancer Centre, Singapore2021-02-01
Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376 (NCT04961632)National Cancer Centre, Singapore2020-12-23
Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin (NCT04620954)National Cancer Centre, Singapore2020-10-07
The Role of Bexarotene in Inducing Susceptibility to Chemotherapy in Metastatic TNBC (NCT04664829)National Cancer Centre, Singapore2020-10-01
Using QPOP to Predict Treatment for Sarcomas and Melanomas (NCT04986748)National Cancer Centre, Singapore2020-09-08
Impact of Measures Taken to Contain COVID-19 on Hospital Surgical Care Services and Clinical Outcomes (NCT04961489)National Cancer Centre, Singapore2020-08-01
Somatostatin Receptor Imaging in NPC, EBV Related Cancers (NCT05581550)National Cancer Centre, Singapore2020-06-29
Phase 2 Trial in Multiple Brain Metastases Outcomes With HA-SIB-WBRT (NCT04452084)National Cancer Centre, Singapore2020-06-15
Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma (NCT04230330)National Cancer Centre, Singapore2019-12-12
Longitudinal Immune-phenotyping of HCC Following MK-3475 (NCT04224480)National Cancer Centre, Singapore2019-12-10
Phase 2 Study of Dacomitinib in NSCLC (NCT04027647)National Cancer Centre, Singapore2019-09-11
Plasma Molecular Profiling in ALK Inhibitor Resistant NSCLC (NCT04087473)National Cancer Centre, Singapore2019-08-23
Window of Opportunity Study in Colorectal Cancer (NCT03984578)National Cancer Centre, Singapore2019-06-12
A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer (NCT05355558)National Cancer Centre, Singapore2019-05-14
Molecular Profiling Project (NCT04025515)National Cancer Centre, Singapore2019-01-11
Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC (NCT03711422)National Cancer Centre, Singapore2018-11-16
LiverMultiScan Analysis of MRI Scans in HCC (NCT04451603)National Cancer Centre, Singapore2018-10-19
Radical Resection and HIPEC for Recurrent Retroperitoneal Sarcoma (NCT03792867)National Cancer Centre, Singapore2018-07-23
Trial Comparing Active Intervention At Diagnosis With Usual Care to Improve Psycho-social Care in AYAO (NCT03515174)National Cancer Centre, Singapore2018-04-16
Effectiveness of the Supportive and Palliative Care Review Kit (SPARK) for Cancer Patients in the Acute Hospital (NCT03330509)National Cancer Centre, Singapore2017-12-01
Prophylactic HIPEC for Colorectal Cancers at High Risk of Developing Peritoneal Metastases (NCT03422432)National Cancer Centre, Singapore2017-09-28
Next →

Track National Cancer Centre, Singapore automatically

Every clearance here is in the API, with alerts when new ones post.